Gallagher Cam
SEC CIK 1557832 · EDGAR
BoughtSold
Most active insiders at IRD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Foundation Fighting Blindness Retinal Degeneration Fund | Dir, See Remarks | — | $15.99M |
| 2 | Gallagher Cam | Dir | $323.9K | — |
| 3 | Magrath George | CEO, Dir | — | $204.9K |
| 4 | Gagnon Robert E. | CFO | — | $190.8K |
| 5 | YERXA BENJAMIN R | Pres, Dir | — | $61.2K |
| 6 | Jayagopal Ashwath | Chief Scientific, Dev. Ofc | — | $58.2K |
| 7 | SCHACHLE JOSEPH K | COO | — | $57.7K |
| 8 | Zaremba Rabourn Amy | Head of Fin. Quality Assurance | — | $23.3K |
| 9 | Bennett Jean | Dir | — | — |
| 10 | Ainsworth Sean | Dir | — | — |
Transactions 46
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-08 16:05 | 2026-09-08 | IRD | Opus Genetics, Inc. | Gallagher Cam | Dir | M - OptEx | $1.15 | +784.3K | 2.80M | +39% | +$902.0K |
| 2026-04-22 16:30 | 2026-04-20 | IRD | Opus Genetics, Inc. | Gallagher Cam | Dir | A - Grant | $0.00 | +24.4K | 2.02M | +1% | $0 | |
| 2026-01-08 | 2026-01-06 | IRD | Opus Genetics, Inc. | Gallagher Cam | Dir | A - Grant | $0.00 | +67.0K | 1.99M | +3% | $0 | |
| 2025-12-31 | 2025-12-29 | IRD | Opus Genetics, Inc. | Gallagher Cam | Dir | P - Purchase | $1.98 | +81.0K | 1.89M | +4% | +$160.4K | |
| 2025-12-31 | 2025-12-31 | IRD | Opus Genetics, Inc. | Gallagher Cam | Dir | A - Grant | $0.00 | +33.0K | 1.92M | +2% | $0 | |
| I | 2025-12-31 | 2025-12-29 | IRD | Opus Genetics, Inc. | Gallagher Cam | Dir | P - Purchase | $1.97 | +83.0K | 83.0K | New | +$163.5K |
| 2025-08-27 | 2025-08-25 | IRD | Opus Genetics, Inc. | Gallagher Cam | Dir | A - Grant | $1.15 | +869.6K | 1.81M | +92% | +$1000.0K | |
| D | 2025-05-02 | 2025-04-30 | IRD | Opus Genetics, Inc. | Gallagher Cam | Dir | A - Grant | $0.00 | +79.5K | 940.9K | +9% | $0 |
| D | 2025-03-26 | 2025-03-24 | IRD | Opus Genetics, Inc. | Gallagher Cam | Dir | A - Grant | — | +784.3K | 861.4K | +1,018% | — |
| D | 2024-06-13 | 2024-06-11 | IRD | Opus Genetics, Inc. | Gallagher Cam | Dir | A - Grant | $0.00 | +41.1K | 77.0K | +115% | $0 |
| 2024-05-31 | 2024-05-31 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Pres, Interim CFO, Dir | S - Sale | $11.98 | -9,597 | 633.7K | -1% | -$115.0K | |
| 2024-02-12 | 2024-02-12 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Pres, Dir | S - Sale | $11.44 | -1,173 | 643.3K | -0.2% | -$13.4K | |
| D | 2024-02-05 | 2024-02-02 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Pres, Dir | S - Sale | $11.54 | -11.6K | 644.5K | -2% | -$133.3K |
| D | 2024-02-05 | 2024-02-01 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Pres, Dir | A - Grant | $0.00 | +192.5K | 656.0K | +42% | $0 |
| D | 2023-06-08 | 2023-06-06 | IRD | Opus Genetics, Inc. | Gallagher Cam | Dir | A - Grant | $0.00 | +11.0K | 35.9K | +44% | $0 |
| M | 2023-05-31 | 2023-05-31 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Pres, Dir | S - Sale | $26.27 | -27.8K | 463.5K | -6% | -$729.6K |
| M | 2023-02-14 | 2023-02-13+ | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Pres, Dir | S - Sale | $20.09 | -11.8K | 491.3K | -2% | -$237.7K |
| M | 2023-02-06 | 2023-02-06 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Pres, Dir | S - Sale | $22.27 | -10.0K | 503.7K | -2% | -$222.7K |
| D | 2023-02-01 | 2023-02-01 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Pres, Dir | A - Grant | $0.00 | +161.1K | 513.1K | +46% | $0 |
| M | 2023-01-18 | 2023-01-17 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Pres, Dir | S - Sale | $24.15 | -10.0K | 352.0K | -3% | -$241.5K |
| D | 2023-01-06 | 2023-01-04 | IRD | Opus Genetics, Inc. | Gallagher Cam | Dir | X - OptEx | $0.00 | +1,574 | 24.9K | +7% | $0 |
| M | 2023-01-05 | 2023-01-05 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Pres, Dir | S - Sale | $21.02 | -10.0K | 362.0K | -3% | -$210.2K |
| M | 2022-11-15 | 2022-11-15 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Pres, Dir | S - Sale | $22.77 | -12.5K | 372.0K | -3% | -$284.7K |
| M | 2022-11-08 | 2022-11-07+ | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Pres, Dir | S - Sale | $23.61 | -24.9K | 396.9K | -6% | -$587.4K |
| 2022-10-17 | 2022-10-17 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Pres, Dir | S - Sale | $23.51 | -12.5K | 409.4K | -3% | -$293.9K | |
| M | 2022-10-07 | 2022-10-05+ | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Pres, Dir | S - Sale | $22.45 | -22.5K | 431.9K | -5% | -$505.2K |
| M | 2022-09-16 | 2022-09-15+ | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Pres, Dir | S - Sale | $24.90 | -22.5K | 454.4K | -5% | -$560.2K |
| D | 2022-05-31 | 2022-05-30 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Pres, Dir | A - Grant | $0.00 | +111.1K | 466.9K | +31% | $0 |
| M | 2022-04-05 | 2022-04-05 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Dir | S - Sale | $50.48 | -10.0K | 358.1K | -3% | -$504.8K |
| M | 2022-03-16 | 2022-03-15 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Dir | S - Sale | $41.92 | -10.0K | 371.2K | -3% | -$419.2K |
| M | 2022-03-08 | 2022-03-07 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Dir | S - Sale | $44.93 | -10.0K | 376.3K | -3% | -$449.3K |
| M | 2022-02-15 | 2022-02-15 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Dir | S - Sale | $51.93 | -10.0K | 387.2K | -3% | -$519.3K |
| DM | 2022-02-14 | 2022-02-10 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Dir | A - Grant | $0.00 | +15.8K | 403.0K | +4% | $0 |
| DM | 2022-02-14 | 2022-02-14 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Dir | S - Sale | $50.19 | -7,188 | 395.8K | -2% | -$360.8K |
| M | 2022-02-07 | 2022-02-07 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Dir | S - Sale | $53.45 | -10.0K | 387.2K | -3% | -$534.5K |
| M | 2022-01-19 | 2022-01-18 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Dir | S - Sale | $62.64 | -10.0K | 398.5K | -2% | -$626.4K |
| M | 2022-01-05 | 2022-01-05 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Dir | S - Sale | $75.49 | -10.0K | 408.5K | -2% | -$754.9K |
| M | 2021-12-16 | 2021-12-15 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Dir | S - Sale | $74.03 | -10.0K | 419.8K | -2% | -$740.3K |
| 2021-12-07 | 2021-12-06 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Dir | S - Sale | $71.33 | -10.0K | 427.2K | -2% | -$713.3K | |
| M | 2021-11-16 | 2021-11-15 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Dir | S - Sale | $75.36 | -10.0K | 437.2K | -2% | -$753.6K |
| M | 2021-11-05 | 2021-11-05 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Dir | S - Sale | $82.95 | -10.0K | 449.6K | -2% | -$829.5K |
| M | 2021-10-04 | 2021-10-01 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Dir | S - Sale | $66.15 | -10.0K | 457.2K | -2% | -$661.5K |
| M | 2021-09-02 | 2021-09-01 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Dir | S - Sale | $67.52 | -10.0K | 467.2K | -2% | -$675.2K |
| M | 2021-08-03 | 2021-08-02 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Dir | S - Sale | $51.02 | -10.0K | 483.4K | -2% | -$510.2K |
| M | 2021-07-08 | 2021-07-06+ | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Dir | S - Sale | $46.92 | -18.4K | 501.3K | -4% | -$861.9K |
| M | 2021-07-06 | 2021-07-02 | ZNTL | Zentalis Pharmaceuticals, Inc. | Gallagher Cam | Dir | S - Sale | $49.58 | -10.0K | 505.6K | -2% | -$495.8K |
Purchase Sale Sale after option exercise All abbreviations